In This Section
SNMMI and ARRS Joint Webinar
Optimizing the Visual and Quantitative Interpretation of I-123 Ioflupane SPECT Brain Imaging
Date: Wednesday, October 2, 2019
Time: 2:00 pm ET
Speaker: Phillip Kuo, MD, PhD
Fee: Complimenary for SNMMI and ARRS members
Credit type/Info: Approximately 1 CE Credit will be offered for physicians, pharmacists, and technologists.
In this one-hour, complimentary webinar, Phillip Kuo, MD, PhD University of Arizona College of Medicine-Tucson will present on the use of I-123 Ioflupane in the diagnosis of Parkinson's disease and the differential diagnosis of Parkinson's disease over other disorders presenting similar symptoms.
I-123 Ioflupane, a nuclear medicine imaging drug, is used to assess dopamine transporters, which help recycle dopamine, a chemical involved in controlling movement.
This webinar is a collaboration between ARRS and SNMMI.
Learning Objectives:
-
Distinguish between a normal I-123 ioflupane scan from an abnormal I-123 ioflupane scan through a comprehensive case review.
-
Identify causes for misinterpretation of I-123 ioflupane. i.e. head tilt, patient motion or interfering patient medications.
-
Describe the complementary utility of software quantification for interpretation
 |
A Collaboration between:
 |
 |